Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial
一线 R-CODOX-M/R-IVAC 化疗治疗高危弥漫性大 B 细胞淋巴瘤(IPI 3-5)可取得良好疗效:一项英国 NCRI II 期试验的结果
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2020.05.016
McMillan, A K; Phillips, E H; Kirkwood, A A; Barrans, S; Burton, C; Rule, S; Patmore, R; Pettengell, R; Ardeshna, K M; Lawrie, A; Montoto, S; Paneesha, S; Clifton-Hadley, L; Linch, D C